Macrocyclic tertiary amine betasecretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005306701 (hide)

Owner Merck & Co., Inc.

Inventors Selnick, Harold G.; Stachel, Shawn J.; Nantermet, Philippe G.; Lindsley, Stacey; Moore, Keith P.; Rajapakse, Hemaka A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005306701

PCT Pub. Number WO2006/055434

Priority 60/628,830 17.11.04 US; 60/653,036 15.02.05 US

Filing date 14 November 2005

Wipo publication date 26 May 2006

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/055434 Priority application(s): WO2006/055434

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306708-Recovery of noble metals from aqueous process streams in the synthesis of glyphosate using adsorption media such as ion exchange resins

2005306700-Closure with one or more lids